USE OF TOPICAL CORTICOSTEROID IN TREATMENT OF ORAL LICHEN PLANUS AND ORAL LICHENOID LESIONS. CLINICAL OUTCOME
The objective was to check clinical outcomes in patients with oral lichen planus and oral lichenoid lesions (OLP & OLL) treated with topical corticosteroids . A cross sectional study was embraced in Lahore at Avicenna Dental College in Oral and Maxillofacial Surgery from July 2017 to June 2019. Among aggregate of 77 patients , sixteen OLP and sixty-one OLL patients were provided with 0.05% Clobetasole Propionate(CP) in aqueous solution and 0.1% triamcinolone acetonide (TA) in orabase (OB), assessing reactions to treatment and follow-up consistence. The results showed that the lesions were atrophic (52/77; 67.5%), extensive (46/77; 59.1%), creating eating difficulties (45/77; 58.4%) and unconstrained pain (25/77; 32.5%); patients were provided with CP-AS and TA-OB . The mean ± sd % of subsequent visits done was 43 ± 32 percent.. Symptoms reduction seen in 44% patients. Consistence in recalled visits appeared unasatisfactory in 66.7 percent of patients. Among 38 patients with consistent symptoms, 64.7% prove all out reduction at treatment finishing; among 24 with recurrent symptoms, 73.1 percent of patients had episodes 2-3 times per year and 51.5 percent controlled episodes with <6 applications of TC. Undesired impacts were seen in only few patients. Our treatment demonstrated exceptionally successful and safe.